We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 277 results
  1. Black-Box Warnings of Antiseizure Medications: What is Inside the Box?

    Antiseizure medications can cause serious adverse reactions and have deleterious drug interactions that often complicate the clinical management of...

    Abdul Wahab, Attiya Iqbal in Pharmaceutical Medicine
    Article 29 April 2023
  2. Effect of dietary supplementation with Lactobacillus helveticus R0052 on seizure thresholds and antiseizure potency of sodium valproate in mice

    Objective

    Both animal and human studies, though limited, showed that multi-strain probiotic supplementation may reduce the number of seizures and/or...

    Piotr Wlaź, Adrian Wiater, ... Katarzyna Socała in Psychopharmacology
    Article Open access 15 November 2023
  3. Alpha-Pinene Exerts Antiseizure Effects by Preventing Oxidative Stress and Apoptosis in the Hippocampus in a Rat Model of Temporal Lobe Epilepsy Induced by Kainate

    Oxidative stress and apoptosis following seizures play pivotal roles in the consequences of repeated seizures. Beneficial effects of alpha-pinene...

    Paria Hashemi, Shamseddin Ahmadi in Molecular Neurobiology
    Article 25 February 2023
  4. Epilepsy and ASM Formulations

    Epilepsy, characterized by abnormalities in neuronal activity, remains a challenge for a significant proportion of patients despite the increasing...
    Nuraziemah Ahmad, Alina Arulsamy, Mohd. Farooq Shaikh in Handbook of Neurodegenerative Disorders
    Living reference work entry 2023
  5. Voltage-Gated Sodium Channels as Drug Targets in Epilepsy-Related Sodium Channelopathies

    Voltage-gated sodium channels (VGSCs) drive cellular excitability in various cells including the neurons of the central nervous system. Genetic...
    Eric R. Wengert, Raquel M. Miralles, Manoj K. Patel in Ion Channels as Targets in Drug Discovery
    Chapter 2024
  6. Pharmacoresistance in Epilepsy From Genes and Molecules to Promising Therapies

    This new edition of Pharmacoresistance in Epilepsy addresses all issues relating to drug-resistance in epilepsy, including studies in patients as...

    Luisa L. Rocha, Alberto Lazarowski, Esper A. Cavalheiro
    Book 2023
  7. Analysis of the action mechanisms and targets of herbal anticonvulsants highlights opportunities for therapeutic engagement with refractory epilepsy

    Epilepsy is a neurological disorder characterized by spontaneous and recurring seizures. It poses significant therapeutic challenges due to diverse...

    Sobia Tabassum, Susan Shorter, Saak V. Ovsepian in Journal of Molecular Medicine
    Article Open access 24 April 2024
  8. Changes in Targets as an Explanation for Drug Resistance in Epilepsy

    Drug resistance in epilepsy is a condition that limits the control of seizure activity. The drug target hypothesis postulates changes in those...
    Christopher Martínez-Aguirre, Daniel Fonseca-Barriendos, ... Luisa L. Rocha in Pharmacoresistance in Epilepsy
    Chapter 2023
  9. Pharmacogenetics in Epilepsy and Refractory Epilepsy

    Pharmacogenomic studies in epilepsy are necessary due to the high prevalence of this disease and the high percentage of drug resistance phenotype....
    Liliana Czornyj, Jerónimo Auzmendi, Alberto Lazarowski in Pharmacoresistance in Epilepsy
    Chapter 2023
  10. On Complexity and Emergence: Linking the Hypotheses of Pharmacoresistance in Epilepsy

    Epilepsy is a complex disease mainly defined by the susceptibility to spontaneous recurrent seizures but is also often associated with complex...
    Gabriel Servilha-Menezes, Alan Talevi, Norberto Garcia-Cairasco in Pharmacoresistance in Epilepsy
    Chapter 2023
  11. Therapeutic Drug Monitoring of Lacosamide in Chinese Pediatric Patients with Epilepsy: Efficacy and Factors Influencing the Plasma Concentration

    Background and Objective

    The impact of individual patient variables on drug metabolism is particularly important for antiseizure medication, and...

    Ting Zhao, Hong-jian Li, ... Lu-hai Yu in European Journal of Drug Metabolism and Pharmacokinetics
    Article 23 November 2022
  12. Why Study Drug-Resistant Epilepsy?

    Drug-resistant epilepsy (DRE) represents an important challenge because currently available pharmacological therapies fail to control this condition....
    Luisa L. Rocha, Esper A. Cavalheiro, Alberto Lazarowski in Pharmacoresistance in Epilepsy
    Chapter 2023
  13. Genes Involved in Pharmacoresistant Epilepsy

    This chapter is devoted to drug-resistant epilepsy and its genetic mechanisms. There are currently six hypotheses proposed for pharmacoresistant...
    Iris E. Martínez-Juárez, Diego A. Barrios-González, ... Antonio V. Delgado-Escueta in Pharmacoresistance in Epilepsy
    Chapter 2023
  14. On the Development of New Drugs for the Treatment of Drug-Resistant Epilepsy: An Update on Different Approaches to Different Hypotheses

    Despite the continuous expansion of the available pharmacological options for the treatment of epilepsies and remarkable advances in understanding...
    Chapter 2023
  15. Application of Proteomics in the Study of Molecular Markers in Epilepsy

    Proteomics has helped us to understand physiological functioning as well as pathological condition. Mesial temporal lobe epilepsy (MTLE), the most...
    Maria José da Silva Fernandes, Andressa Sampaio Pereira, ... Daniele Suzete Persike in Pharmacoresistance in Epilepsy
    Chapter 2023
  16. Clinical management of contrast-induced neurotoxicity: a systematic review

    Background

    Contrast-induced neurotoxicity (CIN) is an increasingly recognised complication following endovascular procedures utilising contrast. It...

    Frederick P. Mariajoseph, Jia ** Chung, ... Lee-Anne Slater in Acta Neurologica Belgica
    Article Open access 08 February 2024
  17. Development of SV2A Ligands for Epilepsy Treatment: A Review of Levetiracetam, Brivaracetam, and Padsevonil

    Epilepsy is a common neurological disorder that is primarily treated with antiseizure medications (ASMs). Although dozens of ASMs are available in...

    Peng-Peng Wu, Bi-Rong Cao, ... Zhao-Bing Gao in Neuroscience Bulletin
    Article 28 October 2023
  18. Contribution of the Antiepileptic Drug Administration Regime to Avoid the Development and/or Establishment of Pharmacoresistant Epilepsy

    Although drug-resistant epilepsy has been explained by different mechanisms, the most accepted one involves overexpression of efflux transporters at...
    Pietro Fagiolino, Marta Vázquez in Pharmacoresistance in Epilepsy
    Chapter 2023
  19. Seizure control by adding on other anti-seizure medication on seizure during levetiracetam administration in patients with glioma-related epilepsy

    Background

    Epilepsy is a major symptom in patients with glioma. Levetiracetam (LEV) is recognized as a first-line treatment for glioma-related...

    Etsuko Yamamoto Hattori, Yoshiki Arakawa, ... Susumu Miyamoto in BMC Cancer
    Article Open access 11 September 2023
  20. GABAergic Neurotransmission Abnormalities in Pharmacoresistant Epilepsy: Experimental and Human Studies

    Despite the fact that there are several drugs available for the treatment of epilepsy, pharmacoresistance remains a major challenge in seizure...
    Sandra Orozco-Suárez, Iris Angélica Feria-Romero, ... Mario A. Alonso-Vanegas in Pharmacoresistance in Epilepsy
    Chapter 2023
Did you find what you were looking for? Share feedback.